Where is Trase headquartered?

Trase is headquartered in McLean, Virginia, USA. The company has a team of 101-500 people.

When was Trase founded?

Trase was founded in 2023. It is based in McLean, Virginia, USA.

Who is the CEO of Trase?

Grant Verstandig is the CEO of Trase. The company was founded in 2023.

Where is Trase located?

Trase is headquartered in McLean, Virginia, USA.

What funding stage is Trase at?

Trase is currently at the Seed stage.

How many employees does Trase have?

Trase has approximately 101-500 employees.

Trase

Category: AI Agents

Trase builds an AI agent operating system for regulated industries, enabling compliant, governed deployment of AI agents across healthcare, defense, and government enterprises. Trase was founded in 2023. The company is led by Grant Verstandig. Based in McLean, Virginia, USA. Team size: 101-500. Total funding raised: $117.5M. Latest round: Seed. Key investors include ARCH Venture Partners, Red Cell Partners, Virginia Innovation Partnership Corporation (VIPC) / Virginia Venture Partners.

Founded: 2023
Headquarters: McLean, Virginia, USA
Team size: 101-500
Total funding: $117.5M

Value proposition

Trase provides a governed AI agent operating system that enables regulated enterprises (healthcare, defense, government) to deploy compliant, secure, and auditable AI agents within weeks — without moving their data or losing control. The company uses a unique outcomes-based pricing model (charging based on efficiency gains rather than upfront fees).

Products and solutions

Trase Origin (OS) — agent orchestration, governance, and security layer across cloud/on-prem/edge, Trase Arena (SDK) — build and launch custom agents on Trase OS, Trase Leagues (Agents) — pre-built specialized agents for nurse rostering, contract intelligence, policy enforcement, insurance verification, audit trail, claims scrubbing, prior authorization, credentialing, and more

Unique value

"Governed AI for Healthcare, Government, and Enterprise" — an agentic operating system built on compliance, governance, and configurability so every agent runs reliably while ensuring data sovereignty.

Target customer

Healthcare systems and hospitals (e.g. Duke Health), U.S. Department of Defense / Navy, government agencies, and regulated enterprises in life sciences, energy, and other compliance-heavy industries

Industries served

Healthcare, National Security / Defense, Government, Oil & Gas / Energy, Life Sciences, Enterprise

Technology advantage

Multi-agent architecture with self-critique and orchestration (hierarchical agent system); fine-tuned LLMs with STaR (Self-Taught Reasoner) technique; code-as-actions for richer expressiveness; reinforcement learning from human feedback; immutable audit trails; unified policy enforcement across environments; 99.8% admin work reduction per benchmarks; topped Hugging Face GAIA leaderboard with 35.55% success rate

How they differentiate

Outcomes-based pricing (charges only when platform delivers measurable efficiency gains); topped Hugging Face GAIA Leaderboard (outperforming Meta, Microsoft, Google, OpenAI); built specifically for HIPAA/SOC 2 compliance and data sovereignty; operates across any cloud, on-prem, or edge; co-developed with end-users (Duke Health cardiologists, Navy operators); judgment layer that determines which decisions need human oversight; Red Cell Partners incubation providing deep domain expertise in healthcare and national security

Main competitors

Palantir (AIP — AI Platform for government/defense), Cognizant (agentic AI for healthcare), Epic Systems (native AI agents like Art/Penny/Emmie for Epic EHR), E:cue (Bethesda-based agentic AI platform)

Key partnerships

Red Cell Partners (incubator and strategic partner), Duke Health (strategic partnership for AI co-development), Virginia Innovation Partnership Corporation (VIPC), Virginia Venture Partners

Notable customers

Duke Health (Duke University Health System — Division of Cardiology), U.S. Navy

Major milestones

September 2024 — Platform development begins, September 2024 — Tops Hugging Face GAIA Leaderboard (first of multiple consecutive weeks at #1), November 2025 — Emerges from stealth with $10.5M pre-seed, hires former AWS Bedrock/SageMaker VP Baskar Sridharan as President, September 2025 — Strategic partnership with Duke Health announced, June 2026 — Raises $107M seed round led by ARCH Venture Partners (one of the largest seed rounds ever), June 2026 — Duke Heart Center AI agent automates fax triage 7.1x faster, saving 1,395 hours/month

Growth metrics

Grew from 30 employees (Nov 2025) to 55 employees (June 2026); Duke Health pilot: fax routing AI handles 5,000+ faxes/month, 7.1x faster, 1,395 hours saved/month, $285K annual staff capacity unlocked

Market positioning

Trase positions itself as a full-stack AI agent operating system for mission-critical, highly regulated environments where Palantir competes in defense but Trase adds healthcare depth, and where traditional healthcare IT vendors lack agentic AI sophistication. The company differentiates through compliance-first design, outcomes-based pricing, and rapid deployment (weeks vs months).

Geographic focus

United States primarily (Northern Virginia / DC metro, Seattle, Durham NC), with hubs in Washington DC metro area and Seattle

About Grant Verstandig

Founder of Red Cell Partners (venture studio); Founder/CEO of Rally Health (acquired by UnitedHealth Group); Senior Advisor to CEO at UnitedHealth Group; Brown University (pre-medical studies)

Official website: https://www.trase.ai/